These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30473186)

  • 41. Airway microbiome, host immune response and recurrent wheezing in infants with severe respiratory syncytial virus bronchiolitis.
    Zhang X; Zhang X; Zhang N; Wang X; Sun L; Chen N; Zhao S; He Q
    Pediatr Allergy Immunol; 2020 Apr; 31(3):281-289. PubMed ID: 31788862
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of the Effects of Active Immunisation against Respiratory Syncytial Virus (RSV) using Decision-Analytic Models: A Systematic Review with a Focus on Vaccination Strategies, Modelling Methods and Input Data.
    Treskova M; Pozo-Martin F; Scholz S; Schönfeld V; Wichmann O; Harder T
    Pharmacoeconomics; 2021 Mar; 39(3):287-315. PubMed ID: 33462760
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The immunogenicity and safety of respiratory syncytial virus vaccines in development: A systematic review.
    Shan J; Britton PN; King CL; Booy R
    Influenza Other Respir Viruses; 2021 Jul; 15(4):539-551. PubMed ID: 33764693
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
    Fleming-Dutra KE; Jones JM; Roper LE; Prill MM; Ortega-Sanchez IR; Moulia DL; Wallace M; Godfrey M; Broder KR; Tepper NK; Brooks O; Sánchez PJ; Kotton CN; Mahon BE; Long SS; McMorrow ML
    MMWR Morb Mortal Wkly Rep; 2023 Oct; 72(41):1115-1122. PubMed ID: 37824423
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children.
    Simões EA; Carbonell-Estrany X; Rieger CH; Mitchell I; Fredrick L; Groothuis JR;
    J Allergy Clin Immunol; 2010 Aug; 126(2):256-62. PubMed ID: 20624638
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Passive and active immunization against respiratory syncytial virus for the young and old.
    Villafana T; Falloon J; Griffin MP; Zhu Q; Esser MT
    Expert Rev Vaccines; 2017 Jul; 16(7):1-13. PubMed ID: 28525961
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential impact of maternal vaccination on life-threatening respiratory syncytial virus infection during infancy.
    Scheltema NM; Kavelaars XM; Thorburn K; Hennus MP; van Woensel JB; van der Ent CK; Borghans JAM; Bont LJ; Drylewicz J
    Vaccine; 2018 Jul; 36(31):4693-4700. PubMed ID: 29941327
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Burden of Respiratory Syncytial Virus Infection in South African Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Pregnant and Postpartum Women: A Longitudinal Cohort Study.
    Madhi SA; Cutland CL; Downs S; Jones S; van Niekerk N; Simoes EAF; Nunes MC
    Clin Infect Dis; 2018 May; 66(11):1658-1665. PubMed ID: 29253090
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Infant Viral Respiratory Infection Nasal Immune-Response Patterns and Their Association with Subsequent Childhood Recurrent Wheeze.
    Turi KN; Shankar J; Anderson LJ; Rajan D; Gaston K; Gebretsadik T; Das SR; Stone C; Larkin EK; Rosas-Salazar C; Brunwasser SM; Moore ML; Peebles RS; Hartert TV
    Am J Respir Crit Care Med; 2018 Oct; 198(8):1064-1073. PubMed ID: 29733679
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The future of respiratory syncytial virus vaccine development.
    Polack FP; Karron RA
    Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S65-73. PubMed ID: 14730272
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence for a causal relationship between respiratory syncytial virus infection and asthma.
    Wu P; Hartert TV
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):731-45. PubMed ID: 21905783
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of respiratory syncytial virus- and rhinovirus-induced bronchiolitis in recurrent wheeze and asthma-A systematic review and meta-analysis.
    Makrinioti H; Hasegawa K; Lakoumentas J; Xepapadaki P; Tsolia M; Castro-Rodriguez JA; Feleszko W; Jartti T; Johnston SL; Bush A; Papaevangelou V; Camargo CA; Papadopoulos NG
    Pediatr Allergy Immunol; 2022 Mar; 33(3):e13741. PubMed ID: 35338734
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis.
    Kurai D; Mizukami A; Preckler V; Verelst F; Molnar D; Matsuki T; Ho Y; Igarashi A
    Expert Rev Vaccines; 2024; 23(1):303-311. PubMed ID: 38426479
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Parent's perception of respiratory syncytial virus and subsequent wheezing burden: A multi-country cross-sectional survey.
    Custovic A; Mestre-Ferrandiz J; Kragten-Tabatabaie L; Laurent J; Sellem L; Koslap-Petraco M; Cadeddu C
    Pediatr Allergy Immunol; 2024 Jun; 35(6):e14169. PubMed ID: 38837464
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunopathology of RSV infection: prospects for developing vaccines without this complication.
    van Drunen Littel-van den Hurk S; Mapletoft JW; Arsic N; Kovacs-Nolan J
    Rev Med Virol; 2007; 17(1):5-34. PubMed ID: 17004293
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study.
    Henderson J; Hilliard TN; Sherriff A; Stalker D; Al Shammari N; Thomas HM
    Pediatr Allergy Immunol; 2005 Aug; 16(5):386-92. PubMed ID: 16101930
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing.
    Simoes EA; Groothuis JR; Carbonell-Estrany X; Rieger CH; Mitchell I; Fredrick LM; Kimpen JL;
    J Pediatr; 2007 Jul; 151(1):34-42, 42.e1. PubMed ID: 17586188
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Wheezing illness caused by respiratory syncytial virus and other agents.
    Yasuno T; Shimizu T; Maeda Y; Yamasaki A; Amaya E; Kawakatsu H
    Pediatr Int; 2008 Aug; 50(4):500-5. PubMed ID: 18937754
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impaired tumor necrosis factor-α secretion by CD4 T cells during respiratory syncytial virus bronchiolitis associated with recurrent wheeze.
    Kitcharoensakkul M; Bacharier LB; Yin-Declue H; Boomer JS; Sajol G; Leung MK; Wilson B; Schechtman KB; Atkinson JP; Green JM; Castro M
    Immun Inflamm Dis; 2020 Mar; 8(1):30-39. PubMed ID: 31901157
    [TBL] [Abstract][Full Text] [Related]  

  • 60. RSV Vaccination Intention Among People Who Are or Plan to Become Pregnant.
    Saper JK; Heffernan M; Simon NE; Davis MM; Macy ML
    Pediatrics; 2024 May; 153(5):. PubMed ID: 38660734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.